New drug shows promise for chronic hives in early trial
NCT ID NCT06603220
First seen May 20, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This study tested a new drug called EVO756 in 30 adults with chronic inducible urticaria, a condition where things like scratching or cold trigger painful hives. The main goal was to see if the drug is safe and tolerable. Researchers also checked if it reduced the number of hives caused by triggers. The study is complete, but results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC INDUCIBLE URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Clinical Research Institute
Tampa, Florida, 33607, United States
-
Aeroallergy Research Laboratories of Savannah, Inc.
Savannah, Georgia, 31406, United States
-
Allergy and Clinical Immunology Associates
Pittsburgh, Pennsylvania, 15241, United States
-
Allergy, Asthma, and Clinical Research Center
Oklahoma City, Oklahoma, 73120, United States
-
Austin Institute for Clinical Research
Pflugerville, Texas, 78660, United States
-
Bexley Dermatology Research
Bexley, Ohio, 43209, United States
-
Cahaba Dermatology & Skin Health Center, LLC
Birmingham, Alabama, 35244, United States
-
California Allergy and Asthma Medical Group
Los Angeles, California, 90025, United States
-
Chesapeake Clinical Research, Inc
White Marsh, Maryland, 21162, United States
-
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana, 46250, United States
-
DelRicht Research
Baton Rouge, Louisiana, 70809, United States
-
Indiana Clinical Trials Center, P.C.
Plainfield, Indiana, 46168, United States
-
Integrative Skin Science and Research
Sacramento, California, 95815, United States
-
OptiSkin Medical
New York, New York, 10128, United States
-
Red River Research Partners
Fargo, North Dakota, 58013, United States
-
Southern Indiana Clinical Trials
New Albany, Indiana, 47150, United States
-
Treasure Valley Medical Research
Boise, Idaho, 83706, United States
-
West Dermatology Research Center
San Diego, California, 92121, United States
Conditions
Explore the condition pages connected to this study.